AI Portfolio Summary
In 2025 Q4, Caligan Partners LP maintained a portfolio of 30 distinct positions. The most significant new addition to the portfolio was MINERALYS THERAPEUTI, which now represents 6.87% of the total fund value. They heavily accumulated shares in REVOLUTION MEDICINES, increasing their position by 20.6%. Conversely, Caligan Partners LP completely exited their position in AGIOS PHARMACEUTICAL.
Total Positions
30
Quarter
2025 Q4
Top Holding
LQDA (23.1%)
Top 10 Concentration
84.2%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 30
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
LQDA
LIQUIDIA CORPOR...
|
Healthcare | 23.05% | 24.18% |
#1
Prev: #1
|
9.2 | no change | no change |
P
S
|
8,118,892 | $280,020,585 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ABVX
ABIVAX SA
|
Healthcare | 16.12% | 16.14% |
#2
Prev: #2
|
6.4 | no change | no change |
P
S
|
1,451,924 | $195,799,211 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 8.42% | 6.51% |
#3
2
Prev: #5
|
5.4 | 219,651 | 20.6% |
P
S
|
1,283,900 | $102,262,635 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 8.28% | 13.77% |
#4
1
Prev: #3
|
3.3 | no change | no change |
P
S
|
2,772,654 | $100,619,614 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MLYS
PUT
MINERALYS THERA...
|
PUT Option | 6.87% | — |
#5
Prev: #—
|
4.7 | 2,298,400 | no change |
NEW
|
2,298,400 | $83,408,936 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PCVX
VAXCYTE INC
|
Healthcare | 6.48% | — |
#6
Prev: #—
|
4.6 | 1,704,815 | no change |
NEW
|
1,704,815 | $78,660,164 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EXEL
EXELIXIS INC
|
Healthcare | 5.60% | 8.25% |
#7
3
Prev: #4
|
4.2 | 27,532 | 1.8% |
P
S
|
1,553,262 | $68,079,473 | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ADMA
ADMA BIOLOGICS ...
|
Healthcare | 4.52% | 5.06% |
#8
Prev: #8
|
3.9 | 375,899 | 14.3% |
P
S
|
3,012,508 | $54,948,146 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 2.72% | — |
#9
Prev: #—
|
3.1 | 3,729,895 | no change |
NEW
|
3,729,895 | $33,046,870 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INBX
INHIBRX BIOSCIE...
|
Healthcare | 2.10% | 1.04% |
#10
5
Prev: #15
|
3.0 | 87,182 | 36.9% |
P
S
|
323,565 | $25,561,635 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TYRA
TYRA BIOSCIENCE...
|
Healthcare | 2.04% | 1.28% |
#11
3
Prev: #14
|
2.9 | 247,432 | 35.5% |
P
S
|
944,257 | $24,824,517 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XENE
PUT
XENON PHARMACEU...
|
PUT Option | 2.03% | — |
#12
Prev: #—
|
2.8 | 549,700 | no change |
NEW
|
549,700 | $24,637,554 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 2.03% | 2.34% |
#13
2
Prev: #11
|
2.9 | 105,100 | 23.6% |
P
S
|
549,665 | $24,635,985 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MAZE
MAZE THERAPEUTI...
|
Healthcare | 1.88% | — |
#14
Prev: #—
|
2.8 | 550,191 | no change |
NEW
|
550,191 | $22,794,413 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RAPT
RAPT THERAPEUTI...
|
Healthcare | 1.80% | — |
#15
Prev: #—
|
2.7 | 644,400 | no change |
NEW
|
644,400 | $21,825,828 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 1.32% | 1.39% |
#16
3
Prev: #13
|
2.5 | 48,200 | 5.8% |
P
S
|
881,533 | $16,008,639 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ANIK
ANIKA THERAPEUT...
|
Healthcare | 1.14% | 1.77% |
#17
5
Prev: #12
|
0.5 | no change | no change |
P
S
|
1,435,130 | $13,791,599 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INBX
CALL
INHIBRX BIOSCIE...
|
CALL Option | 0.98% | — |
#18
Prev: #—
|
2.4 | 150,000 | no change |
NEW
|
150,000 | $11,850,000 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VOR
VOR BIOPHARMA I...
|
Healthcare | 0.82% | — |
#19
Prev: #—
|
2.3 | 925,067 | no change |
NEW
|
925,067 | $9,962,972 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IVA
INVENTIVA SA
|
Healthcare | 0.77% | — |
#20
Prev: #—
|
2.3 | 2,000,000 | no change |
NEW
|
2,000,000 | $9,300,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VRCA
VERRICA PHARMAC...
|
Healthcare | 0.63% | 0.52% |
#21
5
Prev: #16
|
0.3 | no change | no change |
P
S
|
923,910 | $7,677,692 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AGIO
CALL
AGIOS PHARMACEU...
|
CALL Option | 0.20% | — |
#22
Prev: #—
|
2.1 | 90,000 | no change |
NEW
|
90,000 | $2,449,800 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SPRB
SPRUCE BIOSCIEN...
|
Healthcare | 0.15% | — |
#23
Prev: #—
|
2.1 | 20,514 | no change |
NEW
|
20,514 | $1,786,975 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ELDN
ELEDON PHARMACE...
|
Healthcare | 0.07% | — |
#24
Prev: #—
|
2.0 | 555,978 | no change |
NEW
|
555,978 | $839,527 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AGIO
AGIOS PHARMACEU...
|
Healthcare | 0.00% | 5.95% |
Sold All 😨
(Was: #6) |
0.3 | -1,131,205 | -100.0% |
CLOSED
|
— | $— | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AGIO
PUT
AGIOS PHARMACEU...
|
PUT Option | 0.00% | 5.13% |
Sold All 😨
(Was: #7) |
0.3 | -975,000 | -100.0% |
CLOSED
|
— | $— | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EOLS
EVOLUS INC
|
Healthcare | 0.00% | 3.33% |
Sold All 😨
(Was: #9) |
0.3 | -4,138,943 | -100.0% |
CLOSED
|
— | $— | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MRUS
MERUS N V
|
Healthcare | 0.00% | 2.68% |
Sold All 😨
(Was: #10) |
0.3 | -216,954 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SLS
CALL
SELLAS LIFE SCI...
|
CALL Option | 0.00% | 0.48% |
Sold All 😨
(Was: #17) |
0.3 | -2,300,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AURA
AURA BIOSCIENCE...
|
Healthcare | 0.00% | 0.18% |
Sold All 😨
(Was: #18) |
0.3 | -227,174 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 30 holdings